Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.107
https://www.valueinhealthjournal.com/article/S1098-3015(14)02037-3/fulltext
Title :
Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02037-3&doi=10.1016/j.jval.2014.08.107
First page :
A735
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2107